Palisade Bio (PALI)
NASDAQ:PALI
Total Valuation
Palisade Bio has a market cap or net worth of $313.52M. The enterprise value is $180.21M.
Market Cap$313.52M
Enterprise Value$180.21M
Share Statistics
Palisade Bio has 165,884,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding165,884,810
Owned by Insiders0.04%
Owned by Institutions54.66%
Financial Efficiency
Palisade Bio’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -13.91%.
Return on Equity (ROE)-0.13
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-13.91%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee0.00
Profits Per Employee-2.10M
Employee Count8
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Palisade Bio is ―. Palisade Bio’s PEG ratio is 0.08.
PE Ratio―
PS Ratio0.00
PB Ratio1.01
Price to Fair Value1.01
Price to FCF-12.06
Price to Operating Cash Flow-9.70
PEG Ratio0.08
Income Statement
In the last 12 months, Palisade Bio had revenue of 0.00 and earned -16.78M in profits. Earnings per share was -0.30.
Revenue0.00
Gross Profit-3.00K
Operating Income-18.06M
Pretax Income-16.78M
Net Income-16.78M
EBITDA-18.06M
Earnings Per Share (EPS)-0.30
Cash Flow
In the last 12 months, operating cash flow was -10.85M and capital expenditures 0.00, giving a free cash flow of -10.85M billion.
Operating Cash Flow-10.85M
Free Cash Flow-10.85M
Free Cash Flow per Share-0.07
Dividends & Yields
Palisade Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.24
52-Week Price Change158.90%
50-Day Moving Average1.79
200-Day Moving Average1.47
Relative Strength Index (RSI)51.02
Average Volume (3m)4.53M
Important Dates
Palisade Bio upcoming earnings date is Nov 17, 2025, Before Open (Confirmed).
Last Earnings DateAug 19, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend Date―
Financial Position
Palisade Bio as a current ratio of 28.95, with Debt / Equity ratio of 0.05%
Current Ratio28.95
Quick Ratio28.95
Debt to Market Cap<0.01
Net Debt to EBITDA7.38
Interest Coverage Ratio-1.81K
Taxes
In the past 12 months, Palisade Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Palisade Bio EV to EBITDA ratio is 0.14, with an EV/FCF ratio of 0.23.
EV to Sales0.00
EV to EBITDA0.14
EV to Free Cash Flow0.23
EV to Operating Cash Flow0.23
Balance Sheet
Palisade Bio has $133.38M in cash and marketable securities with $71.00K in debt, giving a net cash position of $133.31M billion.
Cash & Marketable Securities$133.38M
Total Debt$71.00K
Net Cash$133.31M
Net Cash Per Share$0.80
Tangible Book Value Per Share$2.32
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Palisade Bio is $10.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$10.67
Price Target Upside464.55% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast71.95%